Filed a patent for "dosing regimens for cyclin-dependent kinase 7 (cdk7) inhibitors" on Thu, February 1, 2024
Filed a patent for "methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists" on Thu, March 28, 2024
